E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/20/2015 in the Prospect News PIPE Daily.

FXCM slips following details of Leucadia financing; SunEdison launches $350 million deal

By Rebecca Melvin

New York, Jan. 20 – FXCM Inc. weakened in active trade on Tuesday following the release of details on the New York-based foreign exchange company’s financing arrangement from Leucadia National Corp.

FXCM shares, which were halted on Friday pending news, reopened Tuesday and promptly collapsed nearly 90% to as low as $1.28.

FXCM was a primary focus of the convertibles market for a second straight day on Tuesday after accounting for the lion’s share of Friday’s action after the company warned of massive client losses tied to a spike in the Swiss franc.

Markets were closed on Monday for the Martin Luther King Jr. holiday.

Elsewhere, Aegerion Pharmaceuticals Inc.’s 2% convertible were indicated to have traded up 5 or 6 points to 90 as shares of the Cambridge, Mass.-based biopharmaceutical company jumped about 10%.

Illumina Inc.’s convertibles were also indicated higher with shares of the San Diego, Calif.-based life sciences company up 7%.

The Illumina 0.25% convertibles were seen up at 235, which was up from 220, according to a market source.

After the market close, SunEdison Inc. launched an offering of $350 million of 7.25-year convertible senior notes that were expected to price late Wednesday and were talked to yield 2.125% to 2.625% with an initial conversion premium of 32.5% to 37.5%.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.